Q4 2025 Holdings
Filed 2026-02-17 | 21 holdings | $969.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $303.8M | 6,897,652 | 31.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $213.1M | 5,871,018 | 22.0% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $109.3M | 12,948,081 | 11.3% |
| Septerna Inc(SEPN) | COM | 81734D104 | $87.8M | 3,149,128 | 9.1% |
| Alumis Inc(ALMS) | COM | 022307102 | $56.2M | 5,756,984 | 5.8% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $35.4M | 1,717,127 | 3.6% |
| Inventiva SA(IVA) | ADS | 46124U107 | $24.2M | 5,194,805 | 2.5% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $22.4M | 7,222,559 | 2.3% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $20.0M | 736,047 | 2.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $16.2M | 2,500,000 | 1.7% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $14.9M | 968,798 | 1.5% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $11.9M | 298,496 | 1.2% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $11.5M | 8,500,000 | 1.2% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $11.0M | 104,817 | 1.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.2M | 75,442 | 1.0% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $7.8M | 1,960,000 | 0.8% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.5M | 3,507,666 | 0.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $4.0M | 60,873 | 0.4% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $2.4M | 204,503 | 0.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $825.8K | 72,245 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $41.0K | 124,119 | 0.0% |